Enfortumab vedotin-ejfv

PDF

HY-P99016A

1 mg,5 mg,10 mg,50 mg

Brand

MCE

Description

Enfortumab vedotin-ejfv is an anti-Nectin-4 antibody-drug conjugate for the management of urothelial carcinoma.

Application

Reactivity

Website

頁面

Photos